Table 1.
Demographic and clinical characteristics of the study population. Mean ± SD are included for continuous variables.
| Demographic and clinical characteristics | Overall cohort (n=456) |
|---|---|
|
| |
| Demographics | |
| age | 60.3±8.3 years |
| Male | 291 (64%) |
| BMI (kg/m2) | 27.2±4.7 |
| CCS 0/CCS 1–99/CCS ≥100 | 31.5%/31.5%/37% |
|
| |
| Cardiovascular risk factors, lipid levels and blood pressure | |
| Diabetes mellitus | 51 (11%) |
| Hypertension | 252 (56%) |
| Hyperlipidemia | 314 (70%) |
| Smoking | 44 (10%) |
| Family history of CAD | 137 (30%) |
| ASCVD risk score | 11.3 ±9.5 |
| Cholesterol level | 207.3±42.0 |
| HDL-/LDL-cholesterol level | 53.7±16.3/127.0±37.5 |
| Systolic/diastolic blood pressure | 133.1±17.4/82.4±10.6 |
|
| |
| Medication (%) | |
| Lipid-lowering medication | 149 (34%) |
| Antihypertensive medication | 147 (36%) |
|
| |
| Cardiac CT measurements | |
| Coronary calcium score | 234±514 |
| EAT volume (cm3) | 83.9±38.0 |
| EAT density (HU) | −76.2±4.32 |
|
| |
| Prospective follow-up (n=292) | |
| Duration of follow-up (years) | 13.2±2.1 |
| Myocardial infarction and cardiac death | 15/292 |
BMI denotes body mass index; CAD, coronary artery disease; CCS, coronary calcium score; EAT, epicardial adipose tissue; HU, Hounsfield units; SD, standard deviation; ASCVD risk score, lifetime risk for atherosclerotic cardiovascular disease.